Cargando…
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, which is characterised by degeneration of distinct neuronal populations, including dopaminergic neurons of the substantia nigra. Here, we use a metabolomics profiling approach to identify changes to lipids in PD observed in sebum,...
Autores principales: | Sinclair, Eleanor, Trivedi, Drupad K., Sarkar, Depanjan, Walton-Doyle, Caitlin, Milne, Joy, Kunath, Tilo, Rijs, Anouk M., de Bie, Rob M. A., Goodacre, Royston, Silverdale, Monty, Barran, Perdita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952564/ https://www.ncbi.nlm.nih.gov/pubmed/33707447 http://dx.doi.org/10.1038/s41467-021-21669-4 |
Ejemplares similares
-
Discovery of Volatile Biomarkers of Parkinson’s
Disease from Sebum
por: Trivedi, Drupad K., et al.
Publicado: (2019) -
Paper Spray Ionization
Ion Mobility Mass Spectrometry
of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s
Disease
por: Sarkar, Depanjan, et al.
Publicado: (2022) -
Validating Differential Volatilome Profiles in Parkinson’s
Disease
por: Sinclair, Eleanor, et al.
Publicado: (2021) -
Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin
por: Spick, Matt, et al.
Publicado: (2021) -
An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics
por: Spick, Matt, et al.
Publicado: (2022)